Michael Midmer is the founder of Zucara Therapeutics. Zucara Therapeutics has raised $50M in total funding. Latest round: Series B.
Michael Midmer is the CEO of Zucara Therapeutics, a diabetes life sciences company, having led the firm since 2016 from preclinical discovery through Phase 2 clinical trials. He has secured over US$50 million in capital for the company, which is developing ZT-01, the first once-daily therapeutic to prevent hypoglycemia in people with diabetes.
Full founder directory · Investor directory · Company funding database · Fundraising library